Lifecode

Foster City, United States Founded: 2012 • Age: 14 yrs Acquired By MedGenome
Molecular tumor profiling panels for solid tumors are developed.
Request Access

About Lifecode

Lifecode is a company based in Foster City (United States) founded in 2012 was acquired by MedGenome in February 2016.. Lifecode has raised $20.5 million across 1 funding round from investors including MedGenome, Sequoia Capital and Mayo Clinic Business Accelerator. Lifecode offers products and services including Pan Cancer Somatic Panel. Lifecode operates in a competitive market with competitors including GRAIL, Color, Strand Life Sciences, Invitae and Genome Medical, among others.

  • Headquarter Foster City, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lifecode, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $20.5 M (USD)

    in 1 rounds

  • Latest Funding Round
    $20.5 M (USD), Series A

    Feb 18, 2015

  • Investors
    MedGenome

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    MedGenome

    (Feb 24, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lifecode

Lifecode offers a comprehensive portfolio of products and services, including Pan Cancer Somatic Panel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Assay for profiling tumors using next-generation sequencing data.

People of Lifecode
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Burt Demill
Chief Commercial Officer
People
Helen Wang
Founding Member & Head, Curation & Quality
People
Dietrich Stephan
Founding Member & Scientist in Chief
People
Chris Rivest
CEO

Unlock access to complete

Funding Insights of Lifecode

Lifecode has successfully raised a total of $20.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $20.5 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $20.5M
  • First Round

    (18 Feb 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2015 Amount Series A - Lifecode Valuation Sequoia Capital , Mayo Clinic Business Accelerator
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lifecode

Lifecode has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include MedGenome, Sequoia Capital and Mayo Clinic Business Accelerator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Sequoia Capital is engaged in venture capital investments.
Founded Year Domain Location
Healthcare startups are accelerated by Mayo Clinic Business Accelerator.
Founded Year Domain Location
DNA sequencing, bioinformatics, and multiomics services are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lifecode

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lifecode

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lifecode Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lifecode

Lifecode operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Strand Life Sciences, Invitae and Genome Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Circulating tumor DNA is screened for early cancer detection.
domain founded_year HQ Location
Cancer care is delivered through a virtual clinic by Color.
domain founded_year HQ Location
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
domain founded_year HQ Location
Home-based genetic tests for detecting diseases are provided to individuals.
domain founded_year HQ Location
Genomic testing services are provided clinically and directly to consumers.
domain founded_year HQ Location
Molecular diagnostics and personalized medicine for cancer are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lifecode

Frequently Asked Questions about Lifecode

When was Lifecode founded?

Lifecode was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is Lifecode located?

Lifecode is headquartered in Foster City, United States. It is registered at Foster City, California, United States.

Is Lifecode a funded company?

Lifecode is a funded company, having raised a total of $20.5M across 1 funding round to date. The company's 1st funding round was a Series A of $20.5M, raised on Feb 18, 2015.

What does Lifecode do?

Lifecode was founded in 2012 in Foster City, United States, as a CLIA-certified laboratory focused on oncology diagnostics. Panels for complete molecular profiling of solid tumors are developed and offered, with the flagship Pan Cancer Somatic Panel analyzing 52 genes linked to metastatic cancers, rare diseases, and clinical trials. The company was acquired by MedGenome in 2016, continuing operations in the biotechnology sector.

Who are the top competitors of Lifecode?

Lifecode's top competitors include GRAIL, Strand Life Sciences and Fulgent Genetics.

What products or services does Lifecode offer?

Lifecode offers Pan Cancer Somatic Panel.

Who are Lifecode's investors?

Lifecode has 3 investors. Key investors include MedGenome, Sequoia Capital, and Mayo Clinic Business Accelerator.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available